The federal government has reached a deal worth up to $2.1 billion with drugmakers Sanofi and GlaxoSmithKline as part of Operation Warp Speed, the Trump administration's push to have a coronavirus vaccine widely available by early 2021.

The money will go toward clinical trials, scaling up manufacturing and purchasing 100 million doses of the vaccine.

Kentucky to Receive Drug Settlement Money

Jul 3, 2012

Kentucky will recover more than $28 million dollars from a legal settlement resolving a dispute with prescription drug maker GlaxoSmithKline.